Indies Pharma Jamaica Limited would like to notify that an error occurred on page 22 of our Annual Report ending 2025, in the section titled “Notice of the Annual General Meeting,” where the year 2024 was incorrectly referenced in three places. The corrections have now been made as follows:
1. RECEIPT OF AUDITED ACCOUNTS
To receive the Audited Accounts for the financial
year of the company ended October 31, 2025,
together with the reports of the Directors and
Auditors thereon, The Company is asked to
consider, and if thought fit, pass the following
resolution:
Ordinary Resolution no. 1:
‘That the Audited Accounts for the financial year
of the Company ended October 31, 2025,
together with the Reports of the Directors and
Auditors thereon be and are hereby adopted’.
3. DIRECTORS REMUNERATION:
To authorize the Board of Directors to approve the
Remuneration of the Directors. The Company is
asked to consider, and if thought fit, to pass the
following resolution:
Ordinary Resolution no. 4:
‘That the amount shown in the Audited Accounts
for the year ended 31 October 2025, as fees to the
Directors for services as Directors, be and is hereby
approved’.
